DILI in Antitubercular Treatment - Current Challenges
Tuberculosis (TB) continues to be a significant infectious disease in many developing countries, and among these countries, India has the highest burden of TB. Addressing the challenges of Drug-Induced Liver Injury (DILI) in antitubercular treatment is crucial for optimizing TB management and improving patient outcomes. In this video, let's take a closer look at the challenges posed by DILI in antitubercular treatment.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article